Clin2
NCT05691036Possibly a fitRecruiting

Studying bile acid levels and genes in pregnancy itching

Intrahepatic Cholestasis of PregnancyGenetic MutationHealth Related Quality of Life

Part of Skin clinical trials.

This study looks at bile acid levels and possible genetic changes in people with persistent pregnancy itching. The goal is to better understand the cause of intrahepatic cholestasis of pregnancy and related pregnancy outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
21 years to 45 years
Study type
Observational

Who can take part

  • You are older than 21 and have ongoing pregnancy itching (pruritus)
  • Blood tests show signs of liver involvement, such as higher ALT/AST or higher bile acids
  • You can understand the study and agree to sign consent before any study steps
  • You plan to stay in the study through delivery (and allow follow-up after delivery)
  • You are willing to share delivery and pregnancy outcome information

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07428226Recruiting
Bile acid tests in pregnancy with liver issues

This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.

Jena, Thuringia
NCT07389031Not yet recruiting· Phase 2
Maralixibat for itching and bile acids during pregnancy

This trial tests if the drug maralixibat can help women with a liver condition called intrahepatic cholestasis of pregnancy (ICP) that causes severe itching and high bile acids. If you are between 20 and 35 weeks pregnant with one healthy baby and have high bile acids, you may be able to join.

Birmingham
NCT07560722Not yet recruiting
Esketamine injection to reduce itching after cesarean delivery

This trial tests whether a single injection of esketamine (a type of anesthetic medication) given during planned cesarean delivery can reduce severe itching caused by intrahepatic cholestasis of pregnancy (a liver condition that develops during pregnancy). If you have this condition and are scheduled for cesarean delivery, this study may help relieve your itching.

Tianjin
NCT06679972Enrolling by invitation
Impact of pregnancy liver condition on baby's breathing

This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.

Bucharest, Bucharest
NCT05197387Recruiting
Study of pregnancy cholestasis and placental inflammation

This study looks at whether a pregnancy liver condition called intrahepatic cholestasis of pregnancy is linked with chronic inflammation in the placenta. It may help doctors better understand risks and what to monitor during pregnancy.

Angers
NCT06777914Recruiting
Genes linked to rare liver disease and cancer risk

This study looks at whether certain family-related genes make people more likely to develop liver or bile duct cancers without a clear cause. If you had surgery or a transplant for one of these cancers and have had unexplained high liver enzymes or itching, this trial may help find genetic clues.

Bologna, Bologna

Hear when a new Intrahepatic Cholestasis of Pregnancy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.